Market World Gastroesophageal Reflux Disease Therapeutics

Gastroesophageal Reflux Disease Therapeutics Market Analysis,
Drivers, Product Scope and Shares Forecasts Till 2025
“Gastroesophageal Reflux Disease Therapeutics Market Report Includes in-
depth analysis of Market Application, Size, Specification, Trends, Major
Manufacturers and Business Strategies by Considering Types, Market
Segmentation and Analysis.”
Industry Insights
The Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market size was valued at USD 5.66 billion
in 2016 and by is estimated to be USD 4.37 billion by 2025, it is anticipated to observe a decrease in its revenue
at a negative CAGR of -2.9%. Expiration of patented blockbuster drugs, which are indicated for the management
of disorders of acid reflux is major restraining factors for this market.
With strong clinical pipelines and patent litigations, the market continues to experience significant changes.
Proton pump inhibitors (PPI) and antagonists of histamine H2 receptor have the importance in current scenario
of the market.
Upon loss of patent protection of formerly leading branded drugs, generic molecules with low-price can ingest
the sales of the branded ones up to 90%. Rising number of companies being exposed to price scrutiny associated
with shift in the focus of government on the promotion of consumer convenience will stimulate further
reduction of drug prices. Although market turnover is affected by the expiration of major patents and the
demand of drugs used to reduce acid, due to the increasing prevalence of heartburn, is anticipated to increase
in the upcoming years.
Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-
reports/gastroesophageal-reflux-disease-gerd-therapeutics-market/request-sample